Topotecan in Treating Children With Refractory Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 1996

Primary Completion Date

January 31, 2001

Conditions
Leukemia
Interventions
DRUG

topotecan hydrochloride

Trial Locations (31)

1211

Clinique de Pediatrie, Geneva

13210

State University of New York - Upstate Medical University, Syracuse

21287

Johns Hopkins Oncology Center, Baltimore

27710

Duke Comprehensive Cancer Center, Durham

28801

Memorial Mission Hospital, Asheville

30322

Emory University Hospital - Atlanta, Atlanta

35294

University of Alabama Comprehensive Cancer Center, Birmingham

48201

Children's Hospital of Michigan, Detroit

53226

Midwest Children's Cancer Center, Milwaukee

60614

Children's Memorial Hospital, Chicago, Chicago

63110

Washington University School of Medicine, St Louis

67214

Via Christi Regional Medical Center, Wichita

70112

MBCCOP - LSU Medical Center, New Orleans

72205

University of Arkansas for Medical Sciences, Little Rock

75230

Medical City Dallas Hospital, Dallas

77030

Baylor College of Medicine, Houston

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

92093-0658

University of California San Diego Cancer Center, La Jolla

32610-100277

Shands Hospital and Clinics, University of Florida, Gainesville

66160-7357

University of Kansas Medical Center, Kansas City

02111

Boston Floating Hospital Infants and Children, Boston

02115

Dana-Farber Cancer Institute, Boston

07601

Hackensack University Medical Center, Hackensack

14263-0001

Roswell Park Cancer Institute, Buffalo

38105-2794

Saint Jude Children's Research Hospital, Memphis

75235-9154

Simmons Cancer Center - Dallas, Dallas

78236-5300

San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

H3H 1P3

Montreal Children's Hospital, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

00936-5067

University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002705 - Topotecan in Treating Children With Refractory Leukemia | Biotech Hunter | Biotech Hunter